Canada Pension Plan Investment Board’s Lexicon Pharmaceuticals LXRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$619K	Buy	+257,900	New	+$502K	﹤0.01%	1186

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Canada Pension Plan Investment Board's LXRX Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 257,900 shares worth $619K. The stake represents ﹤0.01% of the portfolio and ranks #1186 among its holdings.

149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

Canada Pension Plan Investment Board held 257,900 shares of Lexicon Pharmaceuticals worth $619K as of Q2 2026.
Lexicon Pharmaceuticals was a new Canada Pension Plan Investment Board position in Q2 2026.
Lexicon Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1186 holding.
149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.